US$ 29.73
foxo4 dri senolytic 2023 2024 Development of a novel by precise disruption of FOXO4-p53 complex Peptide inhibitors targeting FOXO4-p53 interactions
Description
Primary nerve repair is performed for nerve transection without nerve defects

F.GhediniP

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail

This plays a role in its many functions
